Prostate cancer remains the most common malignancy among U.S. men, and internationally it ranks fourth. Though few studies have offered much insight into what triggers this disease, a growing number ...

Defining Value in Metastatic Prostate Cancer: What Is the Cost of Living Longer and Better? The following represents disclosure information provided by authors of this manuscript. All relationships ...

Last week, Joe Biden was diagnosed with an "aggressive" form of prostate cancer — one that has metastasized to his bones. The discovery of a prostate nodule was made after he sought medical care for ...

Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society. But guidelines for prostate cancer ...

Prostate cancer is the second-leading cause of cancer death in men with more than 34,000 deaths in the U.S. each year, according to the American Cancer Society. But guidelines for prostate cancer ...

Prostate cancer is a common cancer in men that, once it progresses to the later stages, has serious morbidity and mortality consequences as well as burdensome financial issues for patients, the ...

Please provide your email address to receive an email when new articles are posted on . Primary care providers frequently order prostate cancer screenings for older patients, even when they provide ...

A molecular feature in prostate cancer, called endogenous retroviral (ERV) RNA, has been found to have prognostic value and also distinguish differences between men of African and European or Middle ...

At a minimum, the value framework assessment reminds us that there is considerable cost to both patients and society for more effective treatment. Oncologists should include cost in the overall ...